Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

481 trials with published results (13%)

Research Maturity

1820 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.3%

230 terminated out of 3663 trials

Success Rate

88.8%

+2.3% vs benchmark

Late-Stage Pipeline

12%

445 trials in Phase 3/4

Results Transparency

26%

481 of 1820 completed with results

Key Signals

481 with results89% success230 terminated

Data Visualizations

Phase Distribution

2,436Total
Not Applicable (1537)
Early P 1 (18)
P 1 (165)
P 2 (271)
P 3 (183)
P 4 (262)

Trial Status

Completed1,820
Unknown584
Recruiting530
Terminated230
Not Yet Recruiting169
Active Not Recruiting133

Trial Success Rate

88.8%

Benchmark: 86.5%

Based on 1820 completed trials

Clinical Trials (3663)

Showing 20 of 20 trials
NCT07396792Not Yet Recruiting

Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram

NCT07534163Not Yet RecruitingPrimary

III Brazilian Registry of Heart Failure

NCT05834400Not ApplicableCompletedPrimary

Lymphatic System Stimulation in Heart Failure

NCT07304817Phase 2Recruiting

Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)

NCT06874556RecruitingPrimary

A Study of Paramedic HF Management

NCT04323371RecruitingPrimary

Cardiogenic Shock Integrated PHenotyping for Event Reduction

NCT06280820Enrolling By InvitationPrimary

Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)

NCT07532564Completed

Risk Factors, Costs, and Impacts of ED Boarding

NCT07531368Not ApplicableNot Yet RecruitingPrimary

BBAP With CS Mapping Guidance

NCT06935370Phase 3RecruitingPrimary

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

NCT05417490RecruitingPrimary

Factors Influencing Participation in PRADO and Telemedicine Interventions in Heart Failure

NCT06651970Phase 4Recruiting

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

NCT06620653Not ApplicableRecruitingPrimary

Heart Failure Virtual Ward Research Study

NCT06424288Phase 3RecruitingPrimary

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

NCT07531966Recruiting

Vascular Complications After Kidney Transplantation

NCT04264845CompletedPrimary

Patient-Reported Outcomes as an Indicator of Disease Transitions in Heart Failure

NCT07527715Recruiting

Cardiac Magnetic Resonance-Clinical Prediction Model-Dilated Cardiomyopathy

NCT07530029Not Yet Recruiting

Sarcopenia in Older Patients Hospitalized for Acute Heart Failure.

NCT04829617Not ApplicableRecruitingPrimary

Promoting Well-being and Health in Heart Failure

NCT06991257Phase 2RecruitingPrimary

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Scroll to load more

Research Network

Activity Timeline